Non-peptide Inhibitors of Proprotein Convertase Subtilisin Kexins (PCSKs): An Overall Review of Existing and New Data - Colloquium Series on Protein Activation and Cancer (Paperback)
  • Non-peptide Inhibitors of Proprotein Convertase Subtilisin Kexins (PCSKs): An Overall Review of Existing and New Data - Colloquium Series on Protein Activation and Cancer (Paperback)
zoom

Non-peptide Inhibitors of Proprotein Convertase Subtilisin Kexins (PCSKs): An Overall Review of Existing and New Data - Colloquium Series on Protein Activation and Cancer (Paperback)

(author), (author), (author), (author)
£38.50
Paperback 76 Pages / Published: 30/10/2012
  • We can order this

Usually despatched within 3 weeks

  • This item has been added to your basket
The Ca+2-dependent mammalian Proprotein Convertase Subtilisin Kexins (PCSKs) or Proprotein/ Prohormone Convertases (PCs) are a family of endoproteases that play critical roles not only in normal development and metabolism but also in various physiological and pathological conditions. These were initiated by the proteolytic processing of large inactive proproteins into their shorter bioactive mature forms by the PCSK enzymes. These events take place in a highly selective, orchestrated, and stepwise manner. Among the various proprotein substrates of PCSK enzymes, particularly important are the precursor growth factors that include proPDGF-A, B, proIGF-1, 2 and proVEGF-C because of their strong implications in neoplasia initiation, progression, and metastasis. As a result of these findings, PCSK enzymes, particularly furin or PCSK3, became a major target for possible interventions of cancer via the use of their selective inhibitors. Significant progress has been accomplished in the development of peptide and protein-based PCSK inhibitors. However, non-peptide PCSK9 inhibitors are more preferable because of their drug-like and other characteristics. So far, a few non-peptide inhibitors of PCSK enzymes of various types of chemical structures have been described in the literature. These include (i) Carbocyclic compounds of diterpene and streptamine class. (ii) Nitrogen (N)-based heterocyclic compounds of various types and chemical structures such as (a) pyrrolidine bis piperazines, (b) Cu/Zn chelating terpyridine derivatives; (iii) Oxygen (O)-based Heterocyclic compounds of varying types of chemical structures such as (a) Flavonoids, (b) Coumarins of simple and dimeric types, ©Quinonoids, (d) Iridoids; (iv) Aromatic compounds such as (a) Aryl guanidino and amidino derivatives, (b) Naphthyl fluorescein derivative, and ©Phenyl Arsonic acids; and (v) C2-symmetrical aromatic azo-compounds. When measured against a small peptidyl-MCA fluorogenic substrate, these inhibitors displayed IC50 values ranging from nM to ?M. A number of these inhibitors exhibited significant anti-PCSK activity when tested in ex vivo or cell culture conditions. This article provides an overall review of all non-peptide PCSK inhibitors so far reported in the literature along with those we identified recently for the first time and not yet published. The potential implications of these molecules as biochemical, therapeutical, or clinical agents will also be discussed.

Publisher: Morgan & Claypool Publishers
ISBN: 9781615044740
Number of pages: 76
Weight: 145 g
Dimensions: 235 x 187 x 4 mm

You may also be interested in...

Infection & Immunity
Added to basket
Biochemistry for Dummies, 2nd Edition
Added to basket
Introduction to Bioinformatics
Added to basket
Giant Molecules
Added to basket
£16.99
Paperback
BIOS Instant Notes in Biochemistry
Added to basket
Biochemistry Demystified
Added to basket
The Elements of Murder
Added to basket
The Cell: A Very Short Introduction
Added to basket
Oxford Handbook of Medical Sciences
Added to basket
£29.99
Part-work (fascículo)
The Machinery of Life
Added to basket
Chemistry for the Biosciences
Added to basket
A Tale of Seven Elements
Added to basket
The Manga Guide To Biochemistry
Added to basket
The Chemistry of Life
Added to basket

Reviews

Please sign in to write a review

Your review has been submitted successfully.